- Rosiglitazone, a Peroxisome Proliferator-Activated Receptor-gamma Agonist, Restores Alveolar and Pulmonary Vascular Development in a Rat Model of Bronchopulmonary Dysplasia
-
Lee HJ, Lee YJ, Choi CW, Lee JA, Kim EK, Kim HS, Kim BI, Choi JH
- KMID: 1779892
- Yonsei Med J.
- 2014 Jan;55(1):99-106.
- doi: 10.3349/ymj.2014.55.1.99
PURPOSE: We tested whether rosiglitazone (RGZ), a peroxisome proliferator-activated receptor-gamma agonist, can restore alveolar development and vascular growth in a rat model of bronchopulmonary dysplasia (BPD). MATERIALS AND METHODS: A rat... -
- CITED
-
- Close
- SHARE
-
- Close
- Myocardial Protective Effect of Tezosentan, an Endothelin Receptor Antagonist, for Ischemia-Reperfusion Injury in Experimental Heart Failure Models
-
Ryu SM, Kim HJ, Cho KR, Jo WM
- KMID: 1781994
- J Korean Med Sci.
- 2009 Oct;24(5):782-788.
- doi: 10.3346/jkms.2009.24.5.782
The myocardial protective effects of endothelin antagonist in ischemic cardiomyopathy (ICMP), doxorubicin-induced cardiomyopathy (DOX) and pressure-overload hypertrophy by transverse aortic constriction (TAC) models have been predicted to be different. The... -
- CITED
-
- Close
- SHARE
-
- Close
